Karnataka has asked the Centre to extend price safeguards to expensive medicines used for cardiac and kidney diseases after the government approved a 30% trade-margin cap for non-scheduled anti-cancer drugs.
Karnataka has asked the Centre to extend price safeguards to expensive medicines used for cardiac and kidney diseases after the government approved a 30% trade-margin cap for non-scheduled anti-cancer drugs.
<iframe src="https://hindustansphere.com/embed/cluster/2ecf63a752abf242c28e42d1960853c77efae588" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="After Cancer Drug Price Cap, Karnataka Seeks Similar Relief For Heart, Kidney Patients"></iframe>
